Mass spectrometry-based biochemical profiling of SpiN Antigen defines quality control attributes for GMP production

Key Points

• The aim is to define quality control attributes for the production of the spiN antigen using mass spectrometry-based biochemical profiling.
• Mass spectrometry techniques were employed for biochemical profiling
• Quality control attributes were assessed for Good Manufacturing Practice (GMP) production.
• Detailed analysis established specific biochemical markers for spiN antigen
• Findings suggest improved compliance in production standards for biopharmaceuticals